Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
4.2 CHF
−4.79 M CHF
90.14 M CHF
7.09 M
About COSMO PHARM N
Sector
CEO
Giovanni di Napoli
Headquarters
Dublin
Website
Founded
2016
ISIN
NL0011832936
FIGI
BBG00K9Q64N8
Cosmo Pharmaceuticals NV engages in the development and manufacture of treatments and products for gastrointestinal diseases and dermatology. Its products include Lialda/Mezavant/Mesavancol, Uceris/Cortiment, Winlevi, GI Genius, Lumeblue, Aemcolo/Relafalk, Eleview, and Byfavo. The company was founded by Mauro Severino Ajani in 1997 and is headquartered in Dublin, Ireland.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 0RGI is 65.0 CHF — it has increased by 1.09% in the past 24 hours. Watch COSMO PHARMACEUTICALS N.V. EUR0.26 (REGD) stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange COSMO PHARMACEUTICALS N.V. EUR0.26 (REGD) stocks are traded under the ticker 0RGI.
0RGI stock has fallen by −1.52% compared to the previous week, the month change is a −12.63% fall, over the last year COSMO PHARMACEUTICALS N.V. EUR0.26 (REGD) has showed a 78.57% increase.
We've gathered analysts' opinions on COSMO PHARMACEUTICALS N.V. EUR0.26 (REGD) future price: according to them, 0RGI price has a max estimate of 132.75 CHF and a min estimate of 79.14 CHF. Watch 0RGI chart and read a more detailed COSMO PHARMACEUTICALS N.V. EUR0.26 (REGD) stock forecast: see what analysts think of COSMO PHARMACEUTICALS N.V. EUR0.26 (REGD) and suggest that you do with its stocks.
0RGI reached its all-time high on May 11, 2018 with the price of 149.3 CHF, and its all-time low was 33.7 CHF and was reached on Oct 27, 2023. View more price dynamics on 0RGI chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
0RGI stock is 2.04% volatile and has beta coefficient of 0.76. Track COSMO PHARMACEUTICALS N.V. EUR0.26 (REGD) stock price on the chart and check out the list of the most volatile stocks — is COSMO PHARMACEUTICALS N.V. EUR0.26 (REGD) there?
Today COSMO PHARMACEUTICALS N.V. EUR0.26 (REGD) has the market capitalization of 1.03 B, it has decreased by −3.44% over the last week.
Yes, you can track COSMO PHARMACEUTICALS N.V. EUR0.26 (REGD) financials in yearly and quarterly reports right on TradingView.
COSMO PHARMACEUTICALS N.V. EUR0.26 (REGD) is going to release the next earnings report on Mar 19, 2025. Keep track of upcoming events with our Earnings Calendar.
0RGI net income for the last half-year is 73.07 M CHF, while the previous report showed −6.15 M CHF of net income which accounts for 1.29 K% change. Track more COSMO PHARMACEUTICALS N.V. EUR0.26 (REGD) financial stats to get the full picture.
Yes, 0RGI dividends are paid annually. The last dividend per share was 1.95 CHF. As of today, Dividend Yield (TTM)% is 3.04%. Tracking COSMO PHARMACEUTICALS N.V. EUR0.26 (REGD) dividends might help you take more informed decisions.
As of Nov 14, 2024, the company has 325.00 employees. See our rating of the largest employees — is COSMO PHARMACEUTICALS N.V. EUR0.26 (REGD) on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. COSMO PHARMACEUTICALS N.V. EUR0.26 (REGD) EBITDA is 94.77 M CHF, and current EBITDA margin is 20.43%. See more stats in COSMO PHARMACEUTICALS N.V. EUR0.26 (REGD) financial statements.
Like other stocks, 0RGI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade COSMO PHARMACEUTICALS N.V. EUR0.26 (REGD) stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So COSMO PHARMACEUTICALS N.V. EUR0.26 (REGD) technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating COSMO PHARMACEUTICALS N.V. EUR0.26 (REGD) stock shows the neutral signal. See more of COSMO PHARMACEUTICALS N.V. EUR0.26 (REGD) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.